首页> 外文期刊>The Journal of Antibiotics: An International Journal >Ganodermycin, a novel inhibitor of CXCL10 expression from Ganoderma applanatum.
【24h】

Ganodermycin, a novel inhibitor of CXCL10 expression from Ganoderma applanatum.

机译:Ganodermycin是Ganoderma Applanatum的一种新型CXCL10表达的新型抑制剂。

获取原文
获取原文并翻译 | 示例
           

摘要

CXCL10 (inducible protein-10) is a highly inducible chemoattractant, which contributes to the recruitment of inflammatory cells, such as macrophages and T-lymphocytes, and thereby has important roles in chronic inflammatory conditions. In a search for new inhibitors of CXCL10 expression in MonoMac6 cells, a novel compound, designated as Ganodermycin, was isolated from fermentations of the basidiomycete Ganoderma applanatum. The structure was determined by a combination of spectroscopic techniques. Ganodermycin inhibited the lipopolysaccharide (LPS)/interferon (IFN)-gamma-induced CXCL10 promoter activity in transiently transfected MonoMac6 cells in a dose-dependent manner with IC(50) values of 15-20 mug ml(-1) (53-71 muM). Ganodermycin also reduced LPS/IFN-gamma-induced CXCL10 protein synthesis and excretion.
机译:CXCL10(诱导蛋白-10)是一种高度诱导的趋化趋化剂,这有助于募集炎性细胞,例如巨噬细胞和T淋巴细胞,从而在慢性炎症条件下具有重要作用。 在寻找Monomac6细胞中CXCL10表达的新抑制剂,从基于碱霉素Ganoderma Applanatum的发酵中分离出一种称为Ganodermycin的新化合物。 该结构通过光谱技术的组合来确定。 Ganodermycin抑制脂多糖(LPS)/干扰素(IFN)诱导的瞬时转染的单面马克诱导的CXCL10启动子活性,以剂量依赖性方式,IC(50)的IC(50)值为15-20麦克(-1)(53-71 妈妈)。 灵芝也降低了LPS / IFN-GAMMA诱导的CXCL10蛋白合成和排泄。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号